Attitudes towards the Use of Auxiliary Labels among Outpatients in a Community Hospital and 4 Health Promoting Hospitals

Authors

  • Suyapat Konchoho Division of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, KhonKaen University
  • Narumol Jarernsiripornkul Division of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Khon Kaen University

Keywords:

attitudes; auxiliary labels; drug labels; outpatients

Abstract

Background and objectives: Rational Drug Use (RDU) project has been established to solve drug-related problems especially insufficient patients’ knowledge on medication use. Auxiliary labels has been launched to support all patients to get more access in drug labels and increase knowledge of their medications. Therefore, this study aimed to survey attitudes of outpatients towards the use of auxiliary labels and to assess factors related to the patients’ attitudes.

Method: This cross-sectional study was conducted in a community hospital and four health promoting hospitals under the ministry of public health, Nakhon Ratchasima province. The study enrolled patients at the age of 18 and over who had received at least one out of ten drugs including allopurinol, amlodipine, colchicine, domperidone, enalapril, glipizide, ibuprofen, paracetamol, paracetamol mixed with orphenadrine, and simvastatin, and those had at least one month of drug use history. The sample was selected by purposive sampling in the total number of 1,000 respondents (100 for each drug). All patients received a questionnaire about the attitudes towards using auxiliary labels consisting of 14 items. Data was assessed using 5-point Likert scales and interpreted into 3 levels of the patients’ attitudes towards using auxiliary labels as poor, fair and good.

Results: Of the total 1000 patients, 51.8% were females with an average age of 55.61 ± 12.86 years old. The patients expressed their attitudes towards use of auxiliary labels at a good level 35.5% (mean ± SD = 56.58 ± 3.40) and a fair level 64.5% (mean ± SD = 43.34 ± 3.53). The patients strongly agreed with the top 3 following statements about auxiliary labels: "Auxiliary labels are reliable information sources" (32.2%), "If you have any questions about drug use, auxiliary labels will be the first option that you choose to use" (30.3%), and "Auxiliary labels help you remember the names of the drugs you received" (26.9%). Patients strongly disagreed with the top 3 following statements about auxiliary labels: "There is no need to have an auxiliary label for every drug" (32.6%), "Auxiliary labels make you feel uncomfortable to inform healthcare professionals when having side effects” (28.2%), and "When reading auxiliary labels, you want to stop using the medicines" (26.4%). Regarding the multivariate analysis, the independent factors related to better attitudes towards using auxiliary labels including age (OR 0.450, p=0.005), careers (OR 0.474, p=0.005), higher income (OR 6.187, p=0.002) and number of drugs currently used (OR 0.177, p=0.002).

Conclusion: Patients had good attitudes towards auxiliary labels and they were aware of the importance of auxiliary labels. Therefore, strategies to increase patients’ recognition about the importance of auxiliary labels should be promoted. Also, auxiliary labels in all drugs prescribed should be provided to patients to increase knowledge of their medications.

References

1. Phueanpinit P, Pongwecharak J, Krska J, Jarernsiripornkul N. Knowledge and perceptions of the risks of non-steroidal anti-inflammatory drugs among orthopaedic patients in Thailand. Int J Clin Pharm 2016; 38: 1269-1276.
2. Cullen G, Kelly E, Murray FE. Patients’ knowledge of adverse reactions to current medications. Br J ClinPharmacol 2006; 62: 232-236.
3. Dowse R, Barford K, Browne SH. Simple illustrated medicines information improves ARV knowledge and patient self-efficacy in limited literacy South African HIV patients. J Int Assoc Provid AIDS Care 2014; 26: 1400-1406.
4. Jarernsiripornkul N, Patsuree A, Janet K. Survey of patients’ experiences and their certainty of suspected adverse drug reactions. Int J Clin Pharm 2015; 37: 168-174.
5. Kamthieng P, Jankunapas P, Boonyarit P, Sisupan W, Prapaso N. Service plan : Rational Drug Use. Bangkok: Public Health Administration office; 2559.
6. Subcommittee on Reasonable Promotion of Rational Drug Use. Rational Drug Use hospital manual. Bangkok: Agricultural cooperative printing demonstrations of Thai; 2558.
7. Pongpunna S, Jarernsiripornkul N, Pratipanawatr T. Attitude towards usefulness of patient information leaflets among ambulatory patients. Srinagarind Med J 2018; 33(4): 351-358.
8. Becker G, Segal HJ, Einarson TR. Effect of auxiliary prescription labels on the elderly ambulatory patient's drug knowledge. Ann Pharmacother 1989; 23: 324-329.
9. Brown CS, Solovitz BL, Bryant SG, Guernsey BG, Fisher S. Short and long-term effects of auxiliary labels on patient knowledge of precautionary drug information. Drug Intell Clin Pharm 1988; 22: 470-474.
10. Adepu R, Swamy MK. Development and evaluation of patient information leaflets (PIL) usefulness. Indian J Pharm Sci 2012; 74: 174-178.
11. Gremeaux V, Durand S, Benaïm C, Hérisson C, Monleaud J, Hansel S, et al. Evaluation of various ways to deliver information concerning non-steroidal anti-inflammatory drugs to osteoarthritis patients. Ann Phys Rehabil Med 2013; 56: 14-29.
12. Ornbjerg LM, Andersen HB, Kryger P, Cleal B, Hetland ML. What do patients in rheumatologic care know about the risks of NSAIDs? J Clin Rheumatol 2008; 14: 69-73.
13. Patsuree A, Krska J, Jarernsiripornkul N. Experiences relating to adverse drug reactions in the community: a cross-sectional survey among patients and the general public in Thailand. Expert Opin Drug Saf 2016; 15: 287-295.
14. Hamrosi KK, Aslani P, Raynor DK. Beyond needs and expectations: identifying the barriers and facilitators to written medicine information provision and use in Australia. Health Expect 2014; 17: 220-231.
15. Hamrosi KK, Raynor DK, Aslani P. Pharmacist and general practitioner ambivalence about providing written medicine information to patients-a qualitative study. Res Social Adm Pharm 2013; 5; 517-530.
16. Akici A, Kalac S, Toklu HZ, Iskender E, Oktay S. Patient knowledge about drugs prescribed at primary healthcare facilities. Pharmacoepidemiol Drug Saf 2004; 13: 871-876.
17. Wogalter MS, Vigilante WJ. Effects of label format on knowledge acquisition and perceived readability by younger and older adults. Ergon Int J 2003; 46: 327-344.
18. Pohjanoksa-Mäntylä M, Bell JS, Helakorpi S, Närhi U, Pelkonen A, Airaksinen MS. Is the internet replacing health professionals? a population survey on sources of medicines information among people with mental disorders. Soc Psychiatry Psychiatr Epidemiol 2011; 46: 373-379.

Published

2020-09-08

How to Cite

1.
Konchoho S, Jarernsiripornkul N. Attitudes towards the Use of Auxiliary Labels among Outpatients in a Community Hospital and 4 Health Promoting Hospitals. SRIMEDJ [Internet]. 2020 Sep. 8 [cited 2024 May 8];35(5):609-16. Available from: https://li01.tci-thaijo.org/index.php/SRIMEDJ/article/view/246701

Issue

Section

Original Articles